Overview

P4 (Pregabalin for Peripheral Posttraumatic Pain)

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of pregabalin compared to placebo in the treatment of posttraumatic peripheral neuropathic pain
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Pregabalin